NCT04948463 2025-12-24
ELSA-FN
Murdoch Childrens Research Institute
Phase 4 Completed
Clinical Trials
11 trialsNCT03228108 2022-05-10
pro-SWAP
Radboud University Medical Center
Phase 4 Completed
NCT02816112 2020-05-27
REaCT-TC2
Ottawa Hospital Research Institute
Phase 4 Completed
NCT02261896 2019-04-12
Antibiotic Prophylaxis for Endoscopic Ultrasound Guided Fine Needle Aspiration of Pancreatic Cystic Lesions
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
Phase 4 Completed
NCT01279252 2019-01-25
CLEAR
King's College Hospital NHS Trust
Phase 2 Completed
NCT02173262 2017-11-06
OTT14-03
Ottawa Hospital Research Institute
Phase 4 Completed
NCT00590785 2017-08-25
Phase III Comparison of Adjuvant Chemotherapy W/High-Dose Cyclophosphamide Plus Doxorubicin (AC) vs Sequential Doxorubicin Fol by Cyclophosphamide (A-C) in High Risk Breast Cancer Patients With 0-3 Positive Nodes (Intergroup, CALGB 9394)
National Cancer Institute (NCI)
Phase 3 Completed
NCT01649635 2016-07-06
PROSPECTA
Sanofi
Phase 4 Completed
NCT00002850 2015-11-11
Antibiotic Therapy in Preventing Early Infection in Patients With Multiple Myeloma Who Are Receiving Chemotherapy
University of Rochester
Phase 3 Completed
NCT00004216 2013-07-18
VNP20009 in Treating Patients With Advanced or Metastatic Solid Tumors That Have Not Responded to Previous Therapy
National Cancer Institute (NCI)
Phase 1 Completed
NCT00139230 2008-06-03
Combination Chemotherapy for Locally Advanced Squamous Cell Carcinoma of the Head and Neck
Dana-Farber Cancer Institute
Phase 2 Completed